Command Palette

Search for a command to run...

All algorithms

Incidental Renal Mass (CT)

Walk the decision tree step by step, see it as a flowchart, or view the whole algorithm at once.
ACR IFC 2018·reviewed 2026-10-01
  • •Applies to incidental renal masses in asymptomatic adults (≥18 years). Exclude a pseudomass (column of Bertin, scarring), a renal artery aneurysm, a calyceal diverticulum and focal infection first.
  • •Enhancement on CT (Table 3): an increase of ≥20 HU is definite; >10 to <20 HU is equivocal; ≤10 HU is no enhancement. On MRI, a ≥15% signal increase counts as enhancement.
  • •Heterogeneity (Table 1) means wall thickening, one or more septa, a mural nodule, measurable or visible attenuation differences, or calcification.
  • •Too small to characterize (TSTC) means smaller than twice the reconstructed slice thickness. A well-circumscribed, homogeneous TSTC mass that is visually much lower (or, on unenhanced CT, much higher) than the renal parenchyma is probably a benign cyst.
  • •MRI is preferred for masses <1.5 cm and for suspected hypovascular masses. Ultrasound may show that a homogeneous hyperattenuating mass is a hemorrhagic or proteinaceous cyst.
  • •If old images are available, a mass unchanged in imaging features with average growth ≤3 mm per year for at least 5 years is likely of no clinical significance and needs no further workup.
  • •For poor surgical candidates or patients with limited life expectancy, surveillance or no further evaluation is acceptable in place of treatment.

Does the mass contain fat (a region of interest < −10 HU)?

Tip: press 1–3 to choose, Backspace to go back.

Sources

  • Herts BR, et al. Management of the Incidental Renal Mass on CT: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2018;15(2):264-273.
  • Silverman SG, et al. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment. Radiology. 2019;292(2):475-488.source

Educational reference for clinicians — not medical advice. Verify against the primary source before acting on it; guidelines change. Final decisions rest with the interpreting physician and your institution's protocols.